Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Techno DrugsDHA:TECHNODRUG -2.27%37 FCF Margin % is -58.86% as of Mar. 2026. GuruFocus rates DHA:TECHNODRUG with a GF Score™ of 37/100. The stock has 10 warning signs investors should review. Among 962 Drug Manufacturers companies, Techno Drugs ranks worse than 81.08% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Techno Drugs's Free Cash Flow for the
three
months ended in Mar. 2026 was BDT-360 Mil. Techno Drugs's Revenue for the
three
months ended in Mar. 2026 was BDT612 Mil. Therefore, Techno Drugs's FCF Margin % for the quarter that ended in Mar. 2026 was -58.86%.
The historical rank and industry rank for Techno Drugs's FCF Margin % or its related term are showing as below:
DHA:TECHNODRUG'
s FCF Margin % Range Over the Past 10 Years
Min: -19.39 Med: -5.96 Max: 2.31
Current: -19.39
During the past 2 years, the highest FCF Margin % of Techno Drugs was 2.31%. The lowest was -19.39%. And the median was -5.96%.
DHA:TECHNODRUG's FCF Margin % is ranked worse than 81.08% of 962
companies
in the Drug Manufacturers industry
Industry Median: 2.585
vs DHA:TECHNODRUG: -19.39
Techno Drugs FCF Margin % Related Terms
Techno Drugs FCF Margin % Historical Data
* Premium members only.
The historical data trend for Techno Drugs's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:TECHNODRUG vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Techno Drugs's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Drugs FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Techno Drugs's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Techno Drugs's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Techno Drugs (DHA:TECHNODRUG) has a FCF Margin % of -58.86% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Techno Drugs and its competitors. According to the industry distribution chart, Techno Drugs ranks #780 out of 962 companies in the Drug Manufacturers industry, placing it in the top 81.1%.
Is Techno Drugs' FCF Margin % too high?
Techno Drugs' current FCF Margin % is -58.86%. Based on the distribution chart, Techno Drugs ranks #780 out of 962 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Techno Drugs has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Techno Drugs' FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Techno Drugs ranks #780 out of 962 companies for FCF Margin %. This places Techno Drugs in the lower half of its industry. The industry median FCF Margin % is 2.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.59, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Techno Drugs and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Drugs's current FCF Margin % is -58.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Drugs stock overvalued right now?
Techno Drugs (DHA:TECHNODRUG) has a current FCF Margin % of -58.86%. The current FCF Margin % is -58.86%. Techno Drugs' overall GF Score™ is 37/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Techno Drugs (DHA:TECHNODRUG), the current FCF Margin % is -58.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.
37GF Score
Get the complete analysis for DHA:TECHNODRUG
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:TECHNODRUG has been successfully added to your 
